SEC Comment Letter for IMMUNIC, INC. (IMUX) (CIK 0001280776) (IMUX) — Feb 13, 2019

IMMUNIC, INC. (IMUX) (CIK 0001280776)
Date: Feb. 13, 2019 · CIK: 0001280776 · Accession: 0000000000-19-002243

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-229510

Date

February 13, 2019

Author

Michael Swanson

Form

UPLOAD

Company

IMMUNIC, INC. (IMUX) (CIK 0001280776)

Letter

February 13, 2019 Michael Swanson Executive Vice President and Chief Financial Officer VITAL THERAPIES INC 15222-B Avenue of Science San Diego, California 92128 Re:VITAL THERAPIES INC Registration Statement on Form S-4 Filed on February 4, 2019 File No. 333-229510 Dear Mr. Swanson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Todd Schiffman at 202-551-3491 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

February 13, 2019
Michael Swanson
Executive Vice President and Chief Financial Officer
VITAL THERAPIES INC
15222-B Avenue of Science
San Diego, California 92128
Re:VITAL THERAPIES INC
Registration Statement on Form S-4
Filed on February 4, 2019
File No. 333-229510
Dear Mr. Swanson:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Todd Schiffman at 202-551-3491 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io